In sum, we confirmed that tRF-17-79MP9PP significantly suppresses cells malignant activities as a new tumor-suppressor through the THBS1/TGF-β1/Smad3 axis in breast cancer. This evidence concerns the gene SMAD3 and breast carcinoma.